drugset / Trial / NCT07487402
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
NaSequentialOpen-labelTreatment
Summary
A Study of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients with Unresectable Recurrent/Metastatic Hepatocellular Carcinoma.
Timeline
- Start
- 2026-03-30
- Primary completion
- 2028-12-15
- Completion
- 2029-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metabolically Armed GPC3 CAR-T cells | Cell therapy | — | Intravenous |